Harry F. Hixson, Jr.
2014
In 2014, Harry F. Hixson, Jr. earned a total compensation of $220.5K as Director and Former Interim Chief Executive Officer and Principal Financial Officer at Arena Pharmaceuticals, a 3% increase compared to previous year.
Compensation breakdown
| Stock Awards | $164,996 |
|---|---|
| Other | $55,500 |
| Total | $220,496 |
Hixson received $165K in stock awards, accounting for 75% of the total pay in 2014.
Hixson also received $55.5K in other compensation.
Rankings
In 2014, Harry F. Hixson, Jr.'s compensation ranked 12,306th out of 13,032 executives tracked by ExecPay. In other words, Hixson earned more than 5.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,306 out of 13,032 | 6th |
Division Manufacturing | 4,696 out of 4,966 | 5th |
Major group Chemicals And Allied Products | 1,601 out of 1,686 | 5th |
Industry group Drugs | 1,296 out of 1,365 | 5th |
Industry Pharmaceutical Preparations | 995 out of 1,043 | 5th |
Source: SEC filing on April 28, 2017.
Hixson's colleagues
We found six more compensation records of executives who worked with Harry F. Hixson, Jr. at Arena Pharmaceuticals in 2014.
2014
Jack Lief
Arena Pharmaceuticals
Chief Executive Officer
2014
Dominic Behan
Arena Pharmaceuticals
Chief Scientific Officer
2014
Steven Spector
Arena Pharmaceuticals
General Counsel
2014
William Shanahan
Arena Pharmaceuticals
Chief Medical Officer
2014
Robert Hoffman
Arena Pharmaceuticals
Chief Financial Officer
2014
Craig Audet
Arena Pharmaceuticals